Alcohol Treatment Outcomes Following Early vs. Standard Liver Transplant for SAH

Recruiting N/A Interventional Study
Alcohol Use Disorder Alcoholic Hepatitis
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
200 (estimated)
Sponsor
Johns Hopkins University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Given the severe consequences of alcohol relapse following liver transplantation for alcoholic hepatitis (AH-LT), it is critical to accurately identify alcohol use and implement alcohol interventions early in the post-transplant period to optimize patient outcomes. The proposed randomized clinical trial will examine the implementation and effects of integrated, person- and computer-delivered alcoh…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * English speaking Exclusion Criteria: * too medically/psychiatrically ill to participate * not able to provide informed consent due to cognitive impairment
Contacts

MARY E MCCAUL, PhD

410-955-9526

mmccaul1@jhmi.edu

CONTACT

Victor Chen, MD

410-550-1793

pchen37@jhmi.edu

CONTACT